Article

Vistakon preps 1-Day Acuvue Moist contact lenses for U.S.

Jacksonville, FL-The Vistakon division of Johnson & Johnson Vision Care Inc. plans to introduce 1-Day Acuvue Moist brand contact lenses with Lacreon technology in the United States. Currently a leading daily disposable lens in Japan, 1-Day Acuvue Moist was introduced this summer in some U.S. eye-care professionals' offices. Distribution is projected to grow throughout the coming months.

Jacksonville, FL-The Vistakon division of Johnson & Johnson Vision Care Inc. plans to introduce 1-Day Acuvue Moist brand contact lenses with Lacreon technology in the United States. Currently a leading daily disposable lens in Japan, 1-Day Acuvue Moist was introduced this summer in some U.S. eye-care professionals' offices. Distribution is projected to grow throughout the coming months.

Lacreon technology permanently embeds a water-holding ingredient, similar to that found in natural tears, into the etafilcon A material of the 1-Day Acuvue brand. The process keeps the lens moist and comfortable all day, while offering health and convenience benefits of daily disposable contact lenses.

"Many eye-care practitioners and consumers favor disposable contacts because of their health and convenience benefits," explained Pat Cummings, OD, vice president, Professional Affairs, Vistakon. "The addition of Lacreon technology provides a solution for the most frequently reported complaints of contact lens discomfort-dryness and end of day comfort."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.